Trobix Bio

Phage-based Antimicrobial Resistance-sensitizing Solutions

Startup

Trobix Bio is a Netanya-based startup in the Health Tech & Life Sciences sector, established in 2019. Phage-based Antimicrobial Resistance-sensitizing Solutions. The company has raised a total of $8.2M across 4 funding rounds, currently at the A stage. Trobix Bio was founded by Adi Elkeles. Key investors include The Chartered Group, Momentum Fund. The company has 1-10 employees. Core technologies: Biologicals, Molecules.

With $8.2M in total funding, Trobix Bio is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.

$8.2M
Raised
4
Rounds
2
Investors
2
Team
2019
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsMolecules
At a Glance
Investors
Founders
In the News

4 articles covered by sources including www.globenewswire.com, www.prnewswire.com, ramot.org, globaluniversityventuring.com.

www.globenewswire.com · Mar 30, 2023
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
Read article ↗
Frequently Asked Questions
What does Trobix Bio do?

Trobix Bio is an Israeli biotech company pioneering the field of human microbiome via its TBX™ technology platform, utilizing CRISPR, phage and synthetic biology to re-program specific activities in targeted microbiome bacteria and develop orally administered precision oncology therapeutics. Targeting cumulative markets of over $4 billion, Trobix’s preclinical products, TBX201 and TBX301, are being developed to reduce severe diarrhea and colitis in patients receiving irinotecan or checkpoint inhibitors, respectively. Its products may allow physicians to complete more oncology treatments and improve cancer patients’ quality of life. Trobix Bio is a spin-off company of Ramot, the technology-transfer company of Tel Aviv University.

How much funding has Trobix Bio raised?

Trobix Bio has raised $8.2M in total funding across 4 rounds. The company is currently at the A stage. Key investors include The Chartered Group, Momentum Fund.

Who founded Trobix Bio?

Trobix Bio was founded in 2019 by Adi Elkeles (Co-founder & CEO).

What sector is Trobix Bio in?

Trobix Bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is Trobix Bio located?

Trobix Bio is based in HaMelacha St 45, Netanya, Israel, Center District.

View Full Profile Classic View Website ↗